Discovery of a Novel Compound Enhancing SVZ Neurogenic Effects via Human Neural Stem Cell-Based Phenotypic Screening

Read full text Summarise with VIRAT
Authors: Atsushi Nakane, Katsushi Kitahara, Riku Fukushima, Tetsuro Nariai, Kazuto Yamazaki, Hidetaka Nagata
Cited by: 0
References: 67

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background/Objectives: Adult neural stem cells retain the capacity to generate immature neuronal lineages; however, pharmacological approaches that robustly enhance neurogenic activity remain limited. To identify compounds with intrinsic activity under physiologically restrictive conditions, we aimed to screen for small molecules that promote neural stem cell proliferation in the absence of exogenous growth factors and are compatible with central nervous system drug discovery. Methods: We developed a human neural stem cell–based phenotypic screening cascade performed under growth factor–free conditions. Compound activity was evaluated in vitro by ATP-based proliferation assays, BrdU incorporation, and assessment of neurogenic marker analysis. In vivo neurogenic effects were assessed in adult rats by BrdU labeling and immunohistochemical analysis of BrdU/Nestin- and BrdU/DCX-positive cells in the subventricular zone and hippocampal subgranular zone, together with pharmacokinetic analysis to assess brain exposure. Results: Using this platform, we identified Lead-238 as a small-molecule that enhanced neural stem cell proliferation and neurogenic output in vitro. In vivo, Lead-238 increased neurogenic activity in the subventricular zone, as evidenced by elevated numbers of BrdU-positive, BrdU/DCX-positive, and BrdU/Nestin-positive cells, whereas no detectable effects were observed in the hippocampal subgranular zone. Lead-238 achieved sufficient brain exposure, and its neurogenic effects were not readily explained by established neurogenic pathways. Conclusions: These findings demonstrate that growth factor–free phenotypic screening using human neural stem cells is an effective approach for identifying compounds that enhance adult neurogenic activity and identify Lead-238 as a small molecule that increases neurogenic activity in the subventricular zone without detectable effects in the hippocampal subgranular zone.

Fields of Study & Subjects

Neurogenesis and neuroplasticity mechanisms Glioma Diagnosis and Treatment Neuroinflammation and Neurodegeneration Mechanisms

Publication details

Journal / source
Pharmaceuticals
Volume
19
Issue
4
Pages
536–536
Publication date
26 March 2026
Language
EN